Inhibitors of sex steroid biosynthesis and methods for their pro

Details Inhibitors of sex steroid biosynthesis and methods for their pro Inhibitors of sex steroid biosynthesis and methods for their pro

1992-10-22

1994-11-15

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514169, 514172, 514176, 514177, 514178, 514874, 514964, 552526, 552536, 552623, A61K 3156, A61K 3158, C07J 3100

Patent

active

053648471

ABSTRACT:
Certain steroidal and non-steroidal compounds have been found to inhibit androgen and estrogen formation. Such inhibition may aid in the reduction of the activity of these hormones and may be useful in the treatment of diseases where, for example, inhibition of androgen or estrogen acitivity is desired. Preferred inhibitors also possess antiestrogenic activity, thus providing the advantage of a double inhibitory action both on estrogen formation and on estrogen action.

REFERENCES:
patent: 2875199 (1959-02-01), Cella et al.
patent: 3562260 (1971-02-01), Ruggieri et al.
patent: 3975413 (1976-08-01), Pierdet et al.
patent: 3995060 (1976-11-01), Neri et al.
patent: 4055641 (1977-10-01), Benson et al.
patent: 4094994 (1978-06-01), Schonenberger
patent: 4096253 (1978-06-01), Wachter et al.
patent: 4139638 (1979-02-01), Neri et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4191759 (1980-03-01), Johnston et al.
patent: 4235893 (1980-11-01), Brodie et al.
patent: 4307111 (1981-12-01), Crawley
patent: 4386080 (1983-05-01), Crossley et al.
patent: 4472382 (1984-09-01), Labrie
patent: 4536516 (1985-08-01), Harper et al.
patent: 4547493 (1985-10-01), Teutsch et al.
patent: 4623660 (1986-11-01), Richardson
patent: 4634696 (1987-01-01), Teutsch et al.
patent: 4636505 (1987-01-01), Tucker et al.
patent: 4659516 (1987-04-01), Bowler et al.
patent: 4659695 (1987-04-01), Labrie
patent: 4732912 (1988-03-01), Pilgrim et al.
patent: 4751240 (1988-06-01), Bowler et al.
patent: 4760053 (1988-07-01), Labrie
patent: 4760061 (1988-07-01), Edwards et al.
patent: 4822528 (1989-04-01), Colombo et al.
patent: 4833135 (1989-05-01), Edwards et al.
patent: 4874754 (1989-10-01), Nique et al.
patent: 4904661 (1990-02-01), Pilgrim et al.
patent: 4943566 (1990-07-01), Nedelec et al.
patent: 5021414 (1991-06-01), Pilgrim et al.
patent: 5023234 (1991-06-01), Labrie et al.
patent: 5064813 (1991-11-01), Labrie et al.
patent: 5204337 (1993-04-01), Labrie et al.
Wakeling et al., CA 106:149712y (1987).
Wakeling et al., CA 109:104945x (1988).
Wakeling and Bowler, J. Steroid Biochem. vol. 30, No. 1-6, pp. 141-147, 1988.
Seguin et al., Mol. Cell. Endocrinol. 21: pp. 37-41 (1981).
Dobernauer, et al. "Advanced Male Breast Cancer . . . ", Cancer 62:474-478, (1988).
Landvatter et al., J. Med. Chem. pp. 1300-1307, (1982).
Weatherill et al., J. Steroid Biochem. 30: No. 1-6 pp. 263-266 (1988).
Labrie et al., Genitourinary Cancer ISBN 0-89838-830-9, 1987 pp. 157-200.
Von Angerer, et al., J. Med. Chemistry, 1984, 27, 1439-1447.
Wagner et al., 21 Symposium Dstch. Ges. Endodrin. Abstract 52 (1975).
Weiss et al., Angew. Chem./Internat. Edit/vol. 12 (1973) No. 10, p. 841.
New Zealand Patent Office Journal No. 1293 Jan. 1987, #206745.
New Zealand Patent Office Journal No. 1321 vol. 78; #213652 (1985).
New Zealand Patent Office Journal No. 1342 vol. 80 Issue No. 2, #222883 (1991).
Santen et al., p. 1375 No. A22 Abstract (1988).
Mobbs et al., No. 1410 abstract (1988).
Klingmuller et al., p. 1395 No. A62 abstract (1988).
Lefebvre et al., 2-Mammalian Hormones, vol. 99, No. 99; 188132r (1983).
New Zealand Patent Office Journal No. 1266 Abstract No. 201536 (1982).
Doorenbos et al., J. Pharm. Sciences 60:88 1971 pp. 1234-1235.
Heiman et al., J. Med. Chem. 23 (1980) pp. 994-1002.
Fevig et al., Steroids 51 (1988) pp. 471-497.
Mouridsen et al., Cancer Treatment Review 5: pp. 131-141 (1978).
Musto et al. Endocrine Research Comm.; vol. 4, No. 2, 1977 pp. 147-157.
Solo, et al., Steroids vol. 40, No. 6, Dec. 1902, pp. 603-614.
Alan Liss, Inc., "The Prostate" vol. 5, 1984 pp. 123-140.
K. E. H. Gohring et al., World Patent Information vol. 11, No. 1, 1989; pp. 5-10.
Bucourt et al., J. Biol. Chem. 253: 8221 1978.
Auchus et al., Biochem., (1986) 25: 7295-7300.
Auchus et al., (1988) J. Biol. Chem., 263: 11640-11645.
Auchus et al., (1989) Steroids 53: 77-96.
Bhatnagar et al., (1978) J. Biol. Chem. 253: 811-815, 1978.
Chin et al., J. Biol. Chem. 255: 3660-3664 (1980).
Chin et al., J. Biol. Chem. 250: 7682-7686 (1975).
Klijin et al. J. Steroid Biochem. 20 (6B) (1984) p. 1381.
Thomas et al. J. Bio. Chem. 258: (1983) pp. 11500-11504.
Furr et al., J. Endo. 113, No. 3, vol. 113, Jun. 1987 pp. R7-R9.
Jordon et al., Endocrinolgoy 124, No. 4, (1989).
Important Advance in Oncology, Eds: Devita, Hellman and Rosenberg, pp. 193-217 1985.
Salman et al., J. Steroid Biochem, 33, No. 1, pp. 25-31, 1989.
Green et al., Nature, 320: pp. 134-139, Mar. 1986.
Levesque et al., J. Med. Chem, 34, pp. 1624-1630, 1991.
Wakeling, et al. J. Endocr., 112, R7-R10, 1987.
Tora et al. EMBO 8 (7) pp. 1981-1986 (1989).
Doorenbos et al. J. Pharm. Sciences 62, 4, pp. 638-640 (1973).
Doorenbos et al., J. Pharm Sciences 63, 4 pp. 620-622 (1974).
Nayfeh et al., Steroids 14:3 pp. 269-283 (1969).
Levy et al. Biochemistry, 26: 2270-2279 (1987).
McDonald et al., J. Pharm and Exper. Therapeutics 244: pp. 428-431 (1987).
Murdock et al. Biochem. 27: 4432-4438, (1988).
Pittaway D. E. Contraception 27: 431-436, (1983).
Poulin et al., Cancer Res. 46: 4933-4937, (1986).
Strickler et al., J. Biol. Chem. 256: 316-321, (1981).
Thomas et al., J. Biol. Chem. 258: 11500-11504 (1983).
Thomas et al., J. Steroid Biochem. 25: 103-108 (1986).
Thomas et al., J. Biol. Chem. 258: 1587-1590 (1983).
Tobias et al., J. Biol. Chem. 257: 2783-2786 (1982).
Warren et al., Am. J. Obstet. Gynecol. 129: 789-794 (1977).
Lubahn et al., Proc Natl Acad. Sci. 86: 9534-9538 (1989).
Lubahn et al., Science 240: 327-330 (1988).
Luthy et al., J. Steroid Biochem, 31: (5) pp. 845-882 (1988).
Macaulay et al., J. Steroid Biochem. 26: (5) 535-588 (1988).
Simard et al. Mol. Cell. Endocrinology 44: pp. 775-783 1988.
Neumann et al., Clinics in Oncology 1: (1) pp. 41-64 (1982).
Bull et al., J. Chem. Soc. Chem. Comm. pp. 451-453 (1986).
Cooke, Jr., Tetrahedron Letters No. 22, pp. 1983-1986 (1973).
Chang et al., Biochemistry 21: (17) pp. 4103-4109 (1982).
Gibson et al., Angew Chem. Intl. Edit. vol. 7 (12) pp. 919-930 (1968).
Grunwell et al., Steroids 27: (6) pp. 759-771 (1976).
Labrie et al., Satellite Symposium, 7th Intl. Congress of Endocrino, abstract form.
Lee et al., J. Androl. 1981; 2: 293-299.
Labrie et al., J. Steroid Biochem 19: No. 1 pp. 999-1007. (1990).
Labrie et al. The Prostate 4: 579-594 (1983).
Blickenstaff et al., 46: (4 and 5) pp. 889-901 (1985).
Habenicht et al., The Prostate 11: 313-326 (1987).
Gyorki et al., J. Steroid Biochem 25: (3) pp. 355-358 (1986).
Farnsworth, Invest. Urology 6: (4) pp. 423-427 (1969).
Neri et al., J. Stero. Biochem., 6: pp. 815-819 (1975).
Plante et al., J. Steroid Biochem, vol. 13; (1) pp. 61-64 (1988).
Raucher et al. J. Org. Chem 1981, 46, 3558-3559.
Redding et al., Proc. Natl. Acad. Sci. USA vol. 80 pp. 1459-1462 (1983).
Schally et al., Cancer Treatment Reports vol. 68 (1) pp. 281-288 (1984).
Schwarz et al., Organic Synthesis Collective vol. 3: 332-333 (1988).
Voigt et al., Endo 92 (4) pp. 1216-1222, (1973).
Wang et al., Can J. Chem. 65: pp. 2727-2731 (1987).
U.S. Application: 322,154, Filed Mar. 10, 1989, Labrie.

Affiliated with

Also associated with

Rating

Inhibitors of sex steroid biosynthesis and methods for their pro does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of sex steroid biosynthesis and methods for their pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of sex steroid biosynthesis and methods for their pro will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1097844